Table 1.
Participant Characteristics in the First Year the Participant Had 1 Human Immunodeficiency Virus Care Visit, by Gender—North American AIDS Cohort Collaboration on Research and Design, 2001–2015
| Characteristic | Transgender Women | Cisgender Women | Cisgender Men | |||
|---|---|---|---|---|---|---|
| (N = 396) | (N = 14 094) | (N = 101 667) | ||||
| Age, y | ||||||
| Mean (standard deviation) | 37 | (10) | 40 | (10) | 44 | (11) |
| Median (interquartile range) | 36 | (29–43) | 40 | (32–47) | 44 | (37–52) |
| Categorical (n, %) | ||||||
| 18–39 | 255 | 64 | 7214 | 51 | 34 755 | 34 |
| 40–49 | 97 | 24 | 4408 | 31 | 34 768 | 34 |
| 50–59 | 42 | 11 | 1961 | 14 | 23 097 | 23 |
| 60–69 | 2 | 1 | 439 | 3 | 7110 | 7 |
| ≥70 | … | 0 | 72 | 1 | 1937 | 2 |
| Race/ethnicity | ||||||
| White | 92 | 23 | 3405 | 24 | 44 632 | 44 |
| Black | 160 | 40 | 7923 | 56 | 36 348 | 36 |
| Hispanic | 85 | 21 | 919 | 7 | 9586 | 9 |
| Other | 44 | 11 | 914 | 6 | 3798 | 4 |
| Unknown | 15 | 4 | 933 | 7 | 7303 | 7 |
| Human immunodeficiency virus acquisition risk | ||||||
| History of injection drug use | 30 | 8 | 2878 | 20 | 18 947 | 19 |
| Sexual | 314 | 79 | 8564 | 61 | 45 347 | 45 |
| Other | 4 | 1 | 804 | 6 | 1137 | 1 |
| Unknown | 48 | 12 | 1848 | 13 | 36 236 | 36 |